A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. https://t.co/3FQ83se590
47 followers
580 followers
Very nice discussion of cytokine and NO profiles in association with toxicities and outcomes, although little correlation https://t.co/7NPqnjHpWP
629 followers
Here is the article. https://t.co/KO9zzAdRG0
493 followers
RT @COGorg: Just Published! - A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neur…